Theranos’ Lab Practices ‘Pose Immediate Jeopardy to Patient Health,’ According to Government Agency

A letter sent to the controversial blood-testing startup by the Centers for Medicare and Medicaid Services showed that Theranos violated at least five clinical-laboratory regulations.